Triflupromazine has a molecular formula of C18H19F3N2S and a molecular weight of approximately 352.42 g/mol. It is associated with dopamine receptor research, dopamine D1 and D2 receptor pharmacology, monoamine neurotransmission studies, CNS pharmacology, behavioral pharmacology, and small molecule drug development.
Triflupromazine is classified as a phenothiazine-derived typical antipsychotic compound. Phenothiazine antipsychotic compounds are associated with dopamine receptor antagonism and are studied in relation to dopaminergic neurotransmission and central nervous system receptor pathways.
Dopamine receptor signaling is studied in relation to neuronal communication, synaptic signaling, behavioral pathways, mesolimbic signaling, mesocortical pathways, nigrostriatal pathways, and neuropsychiatric pharmacology.
Triflupromazine is also associated with antiemetic pharmacology and research involving dopamine-mediated signaling within the chemoreceptor trigger zone and central emetic pathways.
Triflupromazine Hydrochloride is a separate salt form and should be distinguished from Triflupromazine free base according to the applicable CAS number, molecular formula, molecular weight, salt-form identity, Certificate of Analysis, and approved product specification.
Product identity should be confirmed against the applicable Certificate of Analysis (COA) and approved product specification.
Swapnroop Drugs & Pharmaceuticals is a trusted Triflupromazine API manufacturer and supplier in India, supplying quality-focused active pharmaceutical ingredients for phenothiazine research, dopamine receptor research, antipsychotic pharmaceutical development, central nervous system research, neuropsychopharmacology, dopaminergic signaling research, antiemetic research, analytical development, and global pharmaceutical requirements.
Our Triflupromazine API is supplied with a strong commitment to quality, regulatory compliance, product consistency, comprehensive documentation, and dependable worldwide distribution.
We support customer-specific specifications while meeting applicable pharmaceutical quality, analytical, and documentation requirements.
Triflupromazine is a phenothiazine antipsychotic active pharmaceutical ingredient associated with dopamine receptor antagonism, dopaminergic neurotransmission, central nervous system pharmacology, neuronal signaling pathways, antiemetic pharmacology, and neuropsychiatric pharmaceutical development.
It is commonly associated with pharmaceutical research and development involving dopamine receptors, dopamine D1 and D2 receptor pathways, monoamine neurotransmission, synaptic signaling, CNS pharmacology, phenothiazine pharmacology, antipsychotic drug development, antiemetic research, and neuropsychiatric pharmaceutical research.
Triflupromazine research
Triflupromazine free base research
Triflupromazine API research
Trifluopromazine research
Fluopromazine research
Phenothiazine research
Phenothiazine compound research
Phenothiazine pharmacology research
Phenothiazine antipsychotic research
Phenothiazine drug development
Typical antipsychotic research
Typical antipsychotic drug development
First-generation antipsychotic research
Antipsychotic pharmaceutical research
Antipsychotic drug development
Dopamine receptor research
Dopamine receptor antagonist research
Dopamine antagonist research
Dopamine D1 receptor research
D1 receptor antagonist research
Dopamine D2 receptor research
D2 receptor research
D2 receptor antagonist research
Dopamine receptor pharmacology
Dopaminergic signaling research
Dopaminergic neurotransmission research
Dopamine signaling pathway research
Dopamine pathway research
Dopamine neurotransmission research
Monoamine neurotransmission research
Monoamine signaling research
Neurotransmitter receptor research
Neurotransmitter signaling research
Synaptic neurotransmission research
Synaptic signaling research
Neuronal signaling research
Neuronal communication research
Central nervous system research
CNS pharmacology research
CNS pharmaceutical research
CNS drug development
Neuropharmacology research
Neuropsychopharmacology research
Psychopharmacology research
Neuropsychiatric pharmaceutical research
Neuropsychiatric drug development
Psychiatric pharmaceutical research
Psychiatric drug development
Schizophrenia-related pharmaceutical research
Psychosis-related pharmaceutical research
Psychotic disorder research
Behavioral pharmacology research
Neurobehavioral research
Brain receptor research
Brain signaling pathway research
Mesolimbic dopamine pathway research
Mesocortical dopamine pathway research
Nigrostriatal dopamine pathway research
Tuberoinfundibular dopamine pathway research
Striatal dopamine research
Limbic system research
Basal ganglia research
Motor pathway research
Dopamine-mediated behavior research
Receptor binding research
Dopamine receptor binding research
D1 receptor binding research
D2 receptor binding research
Radioligand binding research
Functional receptor assay research
Cell-based assay research
GPCR research
G protein-coupled receptor research
Receptor antagonist research
Small molecule receptor antagonist research
Antiemetic research
Antiemetic pharmaceutical research
Antiemetic drug development
Nausea-related pharmaceutical research
Vomiting pathway research
Emesis research
Emetic pathway research
Chemoreceptor trigger zone research
CTZ research
Dopamine-mediated emesis research
Central emetic pathway research
Hiccup-related pharmacology research
Sedative pharmacology research
CNS depressant pharmacology research
Histamine receptor research
Adrenergic receptor research
Cholinergic receptor research
Serotonin receptor research
Multi-receptor pharmacology research
Calmodulin research
Calcium-calmodulin signaling research
Intracellular signaling research
Protein-ligand interaction research
Membrane receptor pharmacology research
Drug-receptor interaction research
Neurotransmitter pharmacology research
Drug response research
Pharmacodynamic research
Pharmacokinetic research
Drug metabolism research
CNS medicinal chemistry research
Phenothiazine medicinal chemistry research
Small molecule drug development
Antipsychotic API development
CNS API development
Neuropsychiatric API development
Pharmaceutical formulation development
Oral formulation development
Tablet formulation development
Immediate-release formulation development
Injectable formulation research
Parenteral formulation research
Active pharmaceutical ingredient development
Pharmaceutical analytical research
Quality control laboratories
Analytical method development
Impurity profiling studies
Related substance studies
Degradation product studies
Stability studies
Reference standard applications
Pharmaceutical R&D
CNS R&D
Neuroscience R&D
Contract manufacturing support
Research and development applications
Trusted API & Pharmaceutical Raw Material Supplier
Quality-Focused Pharmaceutical Materials
COA, MOA & Technical Documentation Support
Customer-Specific Specifications
Reliable Global Supply Chain
Competitive Commercial Pricing
Specialized CNS and Phenothiazine API Supply
Customized Packaging Solutions
Export Documentation Assistance
Professional Technical Support
Timely Worldwide Delivery
Swapnroop Drugs & Pharmaceuticals supplies Triflupromazine API to:
Pharmaceutical Manufacturers
CNS Pharmaceutical Companies
Neuropsychiatric Pharmaceutical Companies
Antipsychotic Drug Developers
Phenothiazine Drug Developers
Dopamine Receptor Drug Developers
D1 Receptor Research Organizations
D2 Receptor Research Organizations
Dopamine Research Organizations
Dopaminergic Signaling Research Organizations
Neurotransmitter Research Organizations
Neuropharmacology Research Organizations
Psychopharmacology Research Organizations
Neuropsychopharmacology Research Organizations
Neuroscience Research Organizations
Central Nervous System Research Organizations
Neuropsychiatric Research Organizations
Psychiatric Pharmaceutical Research Organizations
Schizophrenia Research Organizations
Psychosis Research Organizations
Behavioral Pharmacology Research Organizations
Brain Receptor Research Organizations
Antiemetic Drug Developers
Emesis Research Organizations
Chemoreceptor Trigger Zone Research Organizations
GPCR Research Organizations
Monoamine Research Organizations
Generic Pharmaceutical Companies
Oral Formulation Manufacturers
Tablet Formulation Manufacturers
Injectable Formulation Developers
API Formulation Companies
Pharmaceutical Development Companies
Medicinal Chemistry Research Organizations
Biotechnology Companies
Research Organizations
Contract Research Organizations (CROs)
Contract Development & Manufacturing Organizations (CDMOs)
Pharmaceutical R&D Centers
CNS R&D Centers
Neuroscience R&D Centers
Universities & Research Institutes
Analytical Laboratories
International Pharmaceutical Buyers
Located in Chhatrapati Sambhajinagar (Aurangabad), Maharashtra, India, we support domestic and international pharmaceutical supply requirements with efficient logistics and export documentation assistance.
We support Triflupromazine API enquiries from pharmaceutical companies, CNS pharmaceutical organizations, neuropsychiatric pharmaceutical companies, antipsychotic drug developers, phenothiazine research organizations, dopamine receptor research organizations, D1 and D2 receptor research organizations, antiemetic research organizations, neuroscience organizations, formulation manufacturers, medicinal chemistry organizations, biotechnology companies, research institutes, analytical laboratories, and international pharmaceutical buyers across India and global markets.
Our team assists customers with:
Product Specifications
Certificate of Analysis (COA)
Technical Documentation
Packaging Options
Commercial Quotations
Export Documentation
Worldwide Shipping Support
Supply enquiries are subject to product availability, customer verification, intended end-use, intellectual property considerations, applicable pharmaceutical regulations, destination-country requirements, and regulatory requirements.
Get Bulk Quote via WhatsApp